Please use this identifier to cite or link to this item:
Title: Position paper: Rationale for the treatment of children with CCSK in the UMBRELLA SIOP-RTSG 2016 protocol.
Authors: Gooskens, Saskia L
Graf, Norbert
Furtwängler, Rhoikos
Spreafico, Filippo
Bergeron, Christophe
Ramírez-Villar, Gema L
Godzinski, Jan
Rübe, Christian
Janssens, Geert O
Vujanic, Gordan M
Leuschner, Ivo
Coulomb-L'Hermine, Aurore
Smets, Anne M
de Camargo, Beatriz
Stoneham, Sara
van Tinteren, Harm
Pritchard-Jones, Kathy
van den Heuvel-Eibrink, Marry M
International Society of Paediatric Oncology–Renal Tumour Study Group (SIOP–RTSG)
metadata.dc.subject.mesh: Child
Clinical Protocols
Clinical Trials as Topic
Combined Modality Therapy
Kidney Neoplasms
Sarcoma, Clear Cell
Societies, Medical
Issue Date: 27-Feb-2018
Abstract: The International Society of Paediatric Oncology-Renal Tumour Study Group (SIOP-RTSG) has developed a new protocol for the diagnosis, treatment, and follow-up monitoring of childhood renal tumours - the UMBRELLA SIOP-RTSG 2016 protocol (the UMBRELLA protocol). This protocol has been designed to continue international collaboration in the treatment of childhood renal tumours and will be implemented in over 50 different countries. Clear cell sarcoma of the kidney, which is a rare paediatric renal tumour that most commonly occurs in children between 2 and 4 years of age, is specifically addressed in the UMBRELLA protocol.
metadata.dc.identifier.doi: 10.1038/nrurol.2018.14
Appears in Collections:Producción 2020

Files in This Item:
There are no files associated with this item.

This item is protected by original copyright

This item is licensed under a Creative Commons License Creative Commons